Company Name
RONGJIA BIOTECHNOLOGY
Company Introduction
Rongjia Biotech, founded in 2014, is a national high-tech enterprise and a Shanghai “Specialized and Innovative” enterprise. Our company focuses on the research and application of small molecules, macromolecules, and cell analysis technologies, providing comprehensive digital transformation solutions for precision medicine validation and practice. It has established an Academician and Expert Workstation, a Postdoctoral Innovation Practice Base, and an In Vitro Diagnostic Technology Proof-of-Concept Center, and collaborates with multiple universities on scientific research and teaching. Rongjia has built eight core technology platforms: Foresight, MaspEC, Watsonbio, OminExt, AI+, Nucellis, and Yegene.
Size (number of persons)
165
Official website
www.rundarongjia.com
Contact person
Hongqiu Jiang
Contact email
jianghongqiu@rundamedical.com
Product Name
ExoAion
Product Introduction + Highlights
ExoAion establishes the industrial benchmark for natural exosomes by bridging academic research and scalable manufacturing. As active contributors to national standards, the company ensures quality through its proprietary “Five Golden Standards” protocol and clinical-level R&D expertise. It has resolved the industry’s scale limitations with a 100L+ large-scale production facility and proprietary filtration technology, delivering high-purity exosomes (10¹⁰–10¹¹ particles/mL) with a shelf life exceeding two years. Clinically oriented, its solutions support post-procedure recovery by modulating inflammation and activating key pathways such as AQP3 to accelerate skin repair and reduce PIH risk. Backed by a bioactive library of 300+ natural sources and over 100 validated cellular functions, ExoAion provides precision-engineered ingredients tailored to specific efficacy goals.
Can the products be experienced on-site?
YES
Are the products certified in Thailand and Malaysia?
NO
Is the product leading in the industry?
NO
Have the products been exported to Europe, America or other countries?
ExoAion has been successfully selected as a Top 20 product in Alibaba’s Overseas Leading Program, reflecting strong recognition from the platform in terms of product competitiveness, market potential, and international operational capability.
Currently, ExoAion is steadily distributed to multiple key global markets through Alibaba International Station and independent brand exhibition platforms. Its customers span North America, Europe, South America, Asia, Africa, and the Middle East, forming a diversified and multi-tiered global distribution network.
Demand for Exhibits
Expand international presence, promote core technologies, explore global partnerships, and seek opportunities for cross-border collaboration and market growth.